Planned Parenthood Accused of Secret Deal on Contraceptive

Planned Parenthood Accused of Secret Deal on Contraceptive

( - A pro-life group is charging Planned Parenthood with having a secret deal with the manufacturer of the "morning after" pill that would enable the nation's largest abortion provider to make millions of dollars in profits selling Plan B kits.

If the Food and Drug Administration (FDA) "gives a green light for over-the-counter distribution, Planned Parenthood stands to take in a minimum $100 million profit over a five-year period from sales of the Plan B 'morning-after' pill," said Jim Sedlak, executive director of American Life League's STOPP International.

"Such action from the FDA would allow Planned Parenthood to take maximum advantage of a sweetheart deal the organization arranged with Plan B's owner, Barr Pharmaceuticals," to buy the drug at below-market cost and undercut other pharmacies' retail prices, he stated.

Sedlak said the details of the business deal were exposed when internal emails of the Planned Parenthood Federation of America (PPFA) were made public during a California court case. These documents show how the organization worked out a secret arrangement with Barr Pharmaceuticals, the owner of the Plan B patent.

Under a five-year agreement, Planned Parenthood would be able to buy Plan B from Barr at bargain-basement prices, undercut local pharmacies and clear an average $20 profit on each Plan B kit, according to Sedlak.

"No matter how you look at it, Planned Parenthood stands to make a tremendous amount of money off of this pill, which can take the lives of innocent pre-born children between fertilization and implantation," said Sedlak.

"This organization shamelessly pushes this drug, ignoring its deadly properties, just to advance its agenda and fatten its coffers," he added.

One of the released documents about the financial dealings was a 2004 email message from the PPFA vice president of medical affairs, Vanessa Cullins, M.D., to all Planned Parenthood affiliate CEOs. In the email, Cullins explained that Barr would offer the organization special pricing of $4.25 for the drug for five years.

STOPP's research shows that, on average, Planned Parenthood clinics nationwide charge $25 for the drug, while the average retail price at pharmacies is $32.

Cullins told affiliates that the agreement with Barr would help Planned Parenthood "develop and protect our market base."

As Cybercast News Service previously reported, Planned Parenthood is performing more abortions than ever -- albeit in fewer clinics -- and relying increasingly on the revenue generated from the procedure.

Following an aggressive marketing campaign, the organization increased its distribution of the "morning-after" pill by 22.2 percent in Fiscal Year 2004. Planned Parenthood's sale of "Emergency Contraception Kits," which contain the morning after pill, has multiplied more than ten-fold in five years -- from 72,024 in FY 1999 to the 774,482 in FY 2004.

"Planned Parenthood's money-making scheme shows us once again this is not a benevolent health-care organization that cares about women and children," said Sedlak. "Rather, this is simply a multi-million-dollar business that profits from selling sex and killing pre-born human beings."

See Earlier Story:
Planned Parenthood: More Abortions, Fewer Clinics (Jan. 18, 2005)

Make media inquiries or request an interview with Randy Hall.

Subscribe to the free daily E-Brief.

E-mail a comment or news tip to Randy Hall.

Send a Letter to the Editor about this article.